Aktis Oncology, Inc. Common stock — Quarterly Financial Statements (NASDAQ:AKTS) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Market Capitalization N/A
Employee 76
Founded 2020
CEO N/A
Website www.aktisoncology.com
Headquarter Delaware, United States
FIGI BBG00ZQS8KZ1
Industry Technology

Notizie

BofA Securities avvia copertura su Akoustis Technologies con rating Buy

BofA Securities initiates coverage on Akoustis Technologies stock with Buy rating

Cowen avvia la copertura di Akoustis Technologies con rating Buy

Cowen initiates Akoustis Technologies stock with Buy rating

JPMorgan avvia la copertura su Akoustis Technologies con rating Overweight

Akoustis Technologies stock initiated with Overweight rating by JPMorgan

Eikon Therapeutics punta a una valutazione di 908,2 milioni di dollari nell’IPO USA

Wednesday Insider Activity: Mitsui’s $55.6M Berkley Buy Leads the Pack

Il direttore di Aktis Oncology Foley acquista azioni per 4,19 milioni di dollari

Aktis Oncology director Foley buys $4.19 million in shares

Aktis Oncology: Fondi MPM acquistano azioni per 20 milioni di dollari

Aktis Oncology: Mpm funds buy shares worth $20m